CAMBRIDGE, Mass., Aug. 11, 2026 /PRNewswire/ — Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it will hold conference calls to discuss its financial results for the six months ended June 30, 2026 and provide a business update.

The English session of the conference call will be held at 8:00 PM on August 26, 2026, Beijing Time (8:00 AM U.S. Eastern Time on August 26, 2026), and the Mandarin session of the conference call will be held at 9:00 AM Beijing Time on August 27, 2026 (9:00 PM U.S. Eastern Time on August 26, 2026).

The conference calls can be accessed by the following links:

For English Session:

Time: August 26, 2026, Wednesday, 8:00 PM Beijing Time

(August 26, 2026, Wednesday, 8:00 AM U.S. Eastern Time)

Webcast and Conference Call Links:

All webcast participants must use the link provided below to complete the online registration process to access the webcast.

For participants who wish to ask live questions during the conference, please complete online registration using the teleconference call link provided below. Upon registration, each participant will receive details for the conference call, including dial-in numbers, and a unique access PIN. Registered participants can dial in from their phone using a dial-in and PIN number or you can choose a "Call Me" option to have the system automatically call them at the start of the conference.

For Mandarin Session:

Time: August 27, 2026, Thursday, 9:00 AM Beijing Time
(August 26, 2026, Wednesday, 9:00 PM U.S. Eastern Time)

Webcast and Conference Call Information:

Alternatively, participants may dial in to the conference call using below dial-in information.

Mainland China +86-4001888938
International +86-01053827720
Taiwan, China +886-277083288
United States +1-2087016888
Singapore +65-31389722
Hong Kong, China +852-51089680
Password:142221

The replay of English session will be available shortly after the call and can be accessed by visiting the Company’s website at https://insilico.com/.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

MILESEEY Earns Top Honors from MyGolfSpy, Golf Monthly, and Golf Digest; Teases New Innovation for Q3 2026

CITY OF INDUSTRY, Calif., May 27, 2026 /PRNewswire/ — MILESEEY Golf, who…

Cellid and Jig.jp Jointly Develop AR Glasses

A Breakthrough in Everyday AR Glasses, delivered through Sabae Design, Japan’s Only…

MDJM Ltd. Discusses Recent Mirai Acquisition

LONDON and TOKYO, July 6, 2026 /PRNewswire/ — MDJM Ltd. (OTCQB: UOKAF)…